Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Journal of the American Veterinary Medical Association|September 1, 1989
Testicular feminization in a catV N Meyers-Wallen, J D Wilson, J E Griffin, et al.World Journal of Urology|June 15, 2000
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase geneM Shalev, B J Miles, T C Thompson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentrationC Thaller, M Shalev, A Frolov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Differential expression of nuclear retinoid receptors in normal and malignant prostatesY Lotan, X C Xu, M Shalev, et al.Human Pathology|August 3, 2000
Cytopathic effect of in situ gene therapy in prostate cancerG Ayala, T M Wheeler, M Shalev, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomyS F Shariat, M Shalev, A Menesses-Diaz, et al.Veterinary and Comparative Oncology|August 21, 2009
Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidenceK U Sorenmo, V M Kristiansen, M A Cofone, et al.The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.Veterinary Pathology|November 15, 2013
Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistryL Peña, A Gama, M H Goldschmidt, et al.Human Gene Therapy|November 1, 2001
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapyB J Miles, M Shalev, E Aguilar-Cordova, et al.Pageof 11